The aim of this study is to analyse the prevalence of overweight and obesity in Bulgarian high risk patients during the period 2007-2014.Design and method:
We analyse the data from Bulgarian cohorts of high risk patients included in both surveys EUROASPIRE (European Action on Secondary and Primary Prevention by Intervention to Reduce Events) III and IV, held in 2007 and 2014. The protocols of EUROASPIRE III and IV trials comprise standard questionnaires used by all countries to determine the patient health status.Results:
88.1% of the patients in EUROASPIRE III are with hypertension (SBP/DBP >140/90 mmHg or >130/80 mmHg for diabetics, or are on therapy). The mean Body Mass Index (BMI) in EUROASPIRE III is 28.4 kg/m2 and the mean waist circumference in men is 99.2 cm and in women 95.8 cm. The prevalence of overweight, defined as BMI >25 kg/m2, is 93%. The prevalence of obesity, defined as BMI >30 kg/m2, is 65%. The prevalence of central obesity (waist circumference >102 cm for men or >88 cm for women) is 81%. All of the patients in EUROASPIRE IV are with hypertension. The prevalence of overweight is 88%. The prevalence of obesity is 50%. The prevalence of central obesity is 86%.Conclusions:
We found a very high prevalence of overweight and obesity among Bulgarian high risk patients with a small decrease of the overweight and obesity during the last 7 years.